RI
RLMD icon

RTW Investments’s Relmada Therapeutics RLMD Stock Holding History

RTW Investments’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,131,835
Closed -$6.4M – 72
2023
Q3 		$6.4M Hold
2,131,835
– – 0.13% 52
2023
Q2 		$5.24M Hold
2,131,835
– – 0.1% 56
2023
Q1 		$4.82M Buy
2,131,835
+64,011
+3% +$221K 0.1% 51
2022
Q4 		$7.22M Sell
2,067,824
-576,651
-22% -$5.06M 0.15% 54
2022
Q3 		$97.9M Buy
2,644,475
+6,894
+0.3% +$191K 2.26% 14
2022
Q2 		$50.1M Buy
2,637,581
+97,507
+4% +$2.13M 1.29% 27
2022
Q1 		$68.6M Buy
2,540,074
+353,750
+16% +$7.31M 1.42% 27
2021
Q4 		$49.3M Buy
2,186,324
+648,298
+42% +$14.4M 0.72% 44
2021
Q3 		$40.3M Hold
1,538,026
– – 0.61% 46
2021
Q2 		$49.2M Buy
1,538,026
+7,309
+0.5% +$254K 0.74% 35
2021
Q1 		$53.9M Buy
1,530,717
+18,044
+1% +$631K 0.84% 35
2020
Q4 		$48.5M Buy
1,512,673
+1,336
+0.1% +$45.9K 0.81% 35
2020
Q3 		$56.9M Buy
1,511,337
+30,485
+2% +$1.18M 1.37% 21
2020
Q2 		$66.3M Buy
1,480,852
+496,310
+50% +$21M 1.86% 17
2020
Q1 		$33.6M Buy
984,542
+320,058
+48% +$12.9M 1.45% 25
2019
Q4 		$25.9M Buy
+664,484
New +$20.2M 0.98% 28

Other funds holding RLMD

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

RTW Investments's RLMD Position: Q4 2023 in Review

RTW Investments sold out of Relmada Therapeutics (RLMD) in Q4 2023, closing a stake of 2,131,835 shares — an estimated $6.4M sold.

RTW Investments first reported a position in RLMD in Q4 2019 and held it in 16 quarters. The position peaked at $97.9M in Q3 2022. 83 funds tracked by Wall St. Rank hold RLMD as of Q4 2023.

  • RTW Investments reported no remaining Relmada Therapeutics position as of Q4 2023 after selling out during the quarter.
  • RTW Investments sold 2,131,835 Relmada Therapeutics shares in Q4 2023, an estimated $6.4M.
  • RTW Investments first reported a position in Relmada Therapeutics in Q4 2019 and held it in 16 quarters.
  • RTW Investments's Relmada Therapeutics position peaked at $97.9M in Q3 2022.
  • 83 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q4 2023.

Based on RTW Investments's 13F filing for Q4 2023, filed 14 Feb 2024.